Wambolt & Associates LLC Sells 1,235 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wambolt & Associates LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 14.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 7,222 shares of the healthcare conglomerate’s stock after selling 1,235 shares during the quarter. UnitedHealth Group makes up 1.2% of Wambolt & Associates LLC’s portfolio, making the stock its 24th biggest position. Wambolt & Associates LLC’s holdings in UnitedHealth Group were worth $3,654,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. NewSquare Capital LLC acquired a new stake in UnitedHealth Group in the 4th quarter valued at $25,000. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. Promus Capital LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $32,000. RPg Family Wealth Advisory LLC bought a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new position in shares of UnitedHealth Group in the fourth quarter valued at $40,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on UNH. KeyCorp reaffirmed an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Hsbc Global Res raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Piper Sandler reduced their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Stephens lifted their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $516.94 on Tuesday. The firm’s 50-day moving average price is $509.71 and its 200-day moving average price is $546.15. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a market capitalization of $472.85 billion, a P/E ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.